Cargando…

Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer

Detalles Bibliográficos
Autores principales:	Gelibter, Alain, Occhipinti, Mario, Pisegna, Simona, Cortellini, Alessio, Cortesi, Enrico, Marchetti, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186849/ https://www.ncbi.nlm.nih.gov/pubmed/32346402 http://dx.doi.org/10.2217/lmt-2019-0016

Ejemplares similares

Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line Treatments
por: Nicolazzo, Chiara, et al.
Publicado: (2021)

Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study
por: Tenuta, Marta, et al.
Publicado: (2021)

Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia
por: Tenuta, Marta, et al.
Publicado: (2023)

Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study
por: Siringo, Marco, et al.
Publicado: (2023)

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice
por: Cortellini, Alessio, et al.
Publicado: (2019)

The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy
por: Botticelli, Andrea, et al.
Publicado: (2020)

Burned-Out Testicular Cancer: Really a Different History?
por: Mosillo, Claudia, et al.
Publicado: (2017)

Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer
por: Raimondi, Cristina, et al.
Publicado: (2019)

Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors
por: Occhipinti, Mario, et al.
Publicado: (2021)

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation
por: Cortellini, Alessio, et al.
Publicado: (2020)

Nuclear BMI-1 expression in laryngeal carcinoma correlates with lymph node pathological status
por: Allegra, Eugenia, et al.
Publicado: (2012)

The role of opioids in cancer response to immunotherapy
por: Botticelli, Andrea, et al.
Publicado: (2021)

Cutoff Points of BMI for Classification of Nutritional Status Using Bioelectrical Impedance Analysis
por: Mialich, Mirele S., et al.
Publicado: (2018)

The Promising Link Among Tumor Mutational Burden, Immune-Related Adverse Events, and Immune Checkpoint Inhibitors Efficacy in SCLC
por: Cortellini, Alessio
Publicado: (2020)

Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study
por: Sciortino, Carolina, et al.
Publicado: (2022)

Hyperprogressive Disease and Early Hypereosinophilia After Anti-PD-1 Treatment: A Case Report
por: Occhipinti, Mario, et al.
Publicado: (2018)

Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario
por: Trevisani, Francesco, et al.
Publicado: (2022)

To Screen or Not to Screen? At Which BMI Cut Point? Comment on “Obesity and BMI Cut Points for Associated Comorbidities: Electronic Health Record Study”
por: Sioka, Chrissa
Publicado: (2022)

Safety and efficacy of combining afatinib and whole-brain radiation therapy in treating brain metastases from EGFR-mutated NSCLC: a case report and literature review
por: Marampon, Francesco, et al.
Publicado: (2022)

The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
por: Botticelli, Andrea, et al.
Publicado: (2022)

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
por: Cortellini, Alessio, et al.
Publicado: (2020)

Smoking and Socio-demographic correlates of BMI
por: Wang, Peizhi, et al.
Publicado: (2016)

Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study
por: Ceccarelli, Fulvia, et al.
Publicado: (2023)

Authors’ Reply to: To Screen or Not to Screen? At Which BMI Cut Point? Comment on “Obesity and BMI Cut Points for Associated Comorbidities: Electronic Health Record Study”
por: Funk, Luke, et al.
Publicado: (2022)

Community-Specific BMI Cutoff Points for South Indian Females
por: Kishore Mohan, K. B., et al.
Publicado: (2011)

Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study
por: Hallan, Supandeep Singh, et al.
Publicado: (2020)

Socioeconomic status, BMI, and brain development in children
por: Dennis, Evan, et al.
Publicado: (2022)

Circulating CD137(+) T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2022)

Correlation of dental caries status with BMI in school children of age 3-16 years- An institutional study
por: Talluri, Devaki, et al.
Publicado: (2023)

Deriving Ethnic-Specific BMI Cutoff Points for Assessing Diabetes Risk
por: Chiu, Maria, et al.
Publicado: (2011)

Optimal BMI cutoff points in obesity screening for Chinese college students
por: Wang, Zheng, et al.
Publicado: (2022)

Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach
por: Botticelli, Andrea, et al.
Publicado: (2023)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
por: Indini, Alice, et al.
Publicado: (2021)

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status
por: Cortellini, Alessio, et al.
Publicado: (2022)

Associations of grandparental diabetes mellitus with grandchild BMI status
por: Lai, Yaping, et al.
Publicado: (2019)

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
por: Cortellini, Alessio, et al.
Publicado: (2019)

Correlation between Oral Health Status (DMFT) and BMI Index in Khuzestan Province, Iran during 2012-2013
por: KHALILINEJAD, Foroogh, et al.
Publicado: (2014)

The Impact of Drug–Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma
por: Mezi, Silvia, et al.
Publicado: (2023)

Behavioural patterns only predict concurrent BMI status and not BMI trajectories in a sample of youth in Ontario, Canada
por: Laxer, Rachel E., et al.
Publicado: (2018)

Are BMI and Sedentariness Correlated? A Multilevel Study in Children
por: Gomes, Thayse Natacha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6url3ghc2k3ujtbmfj08h3f7gu